Literature DB >> 8691499

Cardiac rehabilitation/exercise in patients with implantable cardioverter defibrillators.

A W Friedman, R C Lipman, S J Silver, R A Minella, J L Hoover.   

Abstract

There have been no specific exercise or daily activity guidelines determined for patients with automatic implantable cardioverter defibrillators. Two patients, one with a Ventritex Cadence Model V-100 defibrillator and one with a CPI Ventak Model 1550 defibrillator were enrolled in monitored cardiac rehabilitation. One patient had symptoms of syncope and cardiodefibrillation during a vigorous short walk prior to cardiac rehabilitation and became fearful of any activity. Stress testing on this patient was terminated early because his atrial fibrillation rate approached the defibrillization rate. A low dose of beta blockade was added to his regimen. He underwent repeat stress testing and was placed in cardiac rehabilitation. This patient had no further shocks, and it was assumed that his shock was due to high atrial fibrillation rates. The second patient experienced recurrent shocks on amiodarone, propafenone, and mexiletine with presyncope. However, stress testing did not disclose abnormalities. The patient was fearful of any activity and was placed in cardiac rehabilitation. During an average of 26 sessions of cardiac rehabilitation, no symptoms have been noted, and the patients have returned to a more normal lifestyle. Specific exercise and lifestyle criteria should be given to patients with cardioverter defibrillators. Stress testing with monitored exercise can develop such a program. Larger numbers of patients need to be studied.

Entities:  

Mesh:

Year:  1996        PMID: 8691499      PMCID: PMC2608098     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  6 in total

1.  Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group.

Authors: 
Journal:  J Am Coll Cardiol       Date:  1994-06       Impact factor: 24.094

2.  When should patients with lethal ventricular arrhythmia resume driving? An analysis of state regulations and physician practices.

Authors:  S A Strickberger; C O Cantillon; P L Friedman
Journal:  Ann Intern Med       Date:  1991-10-01       Impact factor: 25.391

3.  Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia. Implications for driving restrictions.

Authors:  G C Larsen; M R Stupey; C G Walance; K K Griffith; J E Cutler; J Kron; J H McAnulty
Journal:  JAMA       Date:  1994-05-04       Impact factor: 56.272

Review 4.  Transvenous endocardial cardioverter defibrillator systems. Is the future here?

Authors:  A S Manolis
Journal:  Arch Intern Med       Date:  1994-03-28

5.  The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias.

Authors:  R N Fogoros; S B Fiedler; J J Elson
Journal:  Ann Intern Med       Date:  1987-11       Impact factor: 25.391

6.  Patients with an implanted cardioverter defibrillator: a new challenge.

Authors:  D M Schuster
Journal:  J Emerg Nurs       Date:  1990 May-Jun       Impact factor: 1.836

  6 in total
  5 in total

1.  [Not Available].

Authors:  W Kamke; M Schranz; C Dovifat; H Völler
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2000-01

2.  Exercise rehabilitation for chronic heart failure patients with cardiac device implants.

Authors:  Robert G Haennel
Journal:  Cardiopulm Phys Ther J       Date:  2012-09

3.  Testing an exercise intervention to improve aerobic conditioning and autonomic function after an implantable cardioverter defibrillator (ICD).

Authors:  Cynthia M Dougherty; Robb W Glenny; Peter J Kudenchuk; Todd E Malinick; Gayle L Flo
Journal:  Pacing Clin Electrophysiol       Date:  2010-03-08       Impact factor: 1.976

4.  Prospective randomized trial of moderately strenuous aerobic exercise after an implantable cardioverter defibrillator.

Authors:  Cynthia M Dougherty; Robb W Glenny; Robert L Burr; Gayle L Flo; Peter J Kudenchuk
Journal:  Circulation       Date:  2015-03-19       Impact factor: 29.690

5.  Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial.

Authors:  A Fitchet; P J Doherty; C Bundy; W Bell; A P Fitzpatrick; C J Garratt
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.